arrow
J

Jonathan L. Bramson

mcmaster university
H指数:56
被引数:9,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows

通过标准化和自动化的激活诱导标记物分析工作流程实现抗原特异性T细胞和Treg的重复性检测

2026-05-190
OAAI
Canagliflozin Is a Novel Androgen Receptor Pathway Inhibitor for Castrate-Sensitive and Castrate-Resistant Prostate Cancer

卡格列净是一种新型雄激素受体通路抑制剂,用于去势敏感和去势抵抗性前列腺癌

2026-04-240
PRE
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference

加拿大细胞治疗移植2024年年度会议摘要

2026-03-040
OAAI
Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents

长期护理和养老院居民的序贯异源双价SARS-CoV-2疫苗接种的体液和细胞免疫原性

Vaccine
IF3.5
2025-12-310
OAAI
IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy

IL-21-reprogrammed Vδ1 T细胞对实体瘤具有杀伤作用,该作用可通过CAR改造增强,以用于现货型免疫疗法。

2025-09-250
OAAI
ACLY inhibition promotes tumour immunity and suppresses liver cancer

ACLY抑制促进肿瘤免疫和抑制肝癌

Nature
IF48.5
2025-07-300
OA
No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations

Benoit JM,Breznik JA,Wu Y,Kennedy A,Liu LM,Cowbrough B,等。在脆弱人群和健康人群中,重复接种SARS-CoV-2疫苗后未发现免疫耗竭的证据。Nat Commun. (2025) 16:5219. doi: 10.1038/s41467-025-60216-3

2025-06-050
OAAI
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study

Xevinapant联合avelumab治疗晚期实体瘤,并在晚期非小细胞肺癌中进行剂量扩展:一项开放标签、非随机 Ib 期研究的探索性生物标志物、安全性和有效性分析

2025-05-080
OA
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care

先前普通感冒冠状病毒暴露对老年群体机构照护环境中严重急性呼吸综合征冠状病毒2疫苗接种或感染免疫应答及风险的最小影响

2025-05-010
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies

具有hla-i类匹配的KRAS突变的结直肠癌和胰腺癌的人源化小鼠模型,用于癌症免疫疗法的临床前评估

2025-02-280
OA
Gluten-Dependent Activation of CD4+ T Cells by MHC Class II-Expressing Epithelium
2024-11-010
PRE
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study
2023-10-112
OAAI
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

SGLT2抑制剂canagliflozin抑制生长并增强前列腺癌对放疗的反应

2023-09-0819
OAAI